Skip to content

Clinical trials

Completed Major Depressive Disorder trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Status: Completed Country / region: China Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20073
20081
20092
20102
20111
20123
20132
20144
20154
20161
20173
20185
20194
20207
20215
20226
20233
20247
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center7
Capital Medical University5
Zhejiang Huahai Pharmaceutical Co., Ltd.4
GlaxoSmithKline3
Hunan Normal University3
Xian-Janssen Pharmaceutical Ltd.3
Xiaomei Shao3
Beijing Greatway Pharmaceutical Technology Co.,Ltd.2
Central South University2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder69
Depressive Disorder4
Depressive Disorder, Treatment-Resistant2
Schizophrenia2
Anhedonia1
Anxiety Disorders1
Asthma1
Bipolar Disorder1
Eosinophilia1
Generalized Anxiety Disorder1

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.